Home

Baker Bros. Investments II, L.P.

CIK 1551132 · last filed 2019-04-10

Baker Bros. Investments II, L.P. is a corporate insider who has filed 9 SEC Form 4 insider transactions across 1 company since 2014. The most recent filing shows the insider sold $9.1M of GHDX on Apr 10, 2019. Across all open-market trades the lifetime net is −$462.7M, making them a net seller over the disclosed history. The firm reports its address in New York, NY. 81 SEC filings were submitted jointly with 14159, L.P.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

9

Lifetime Open-Market Net

-$462.73M

Filer Profile

Reported Address
860 WASHINGTON STREET
3RD FLOOR
NEW YORK, NY 10014
Phone
(212) 339-5600
State of Incorporation
DE
Related Filers
14159, L.P. — 81 joint filings, latest 2019-08-30
667, L.P. — 81 joint filings, latest 2019-08-30
Baker Bros. Investments, L.P. — 81 joint filings, latest 2019-08-30
Baker Brothers Life Sciences LP — 81 joint filings, latest 2019-08-30
Baker/Tisch Investments, LP — 81 joint filings, latest 2019-08-30
BAKER BROS. ADVISORS LP — 80 joint filings, latest 2019-08-30
FELIX BAKER — 80 joint filings, latest 2019-08-30
JULIAN BAKER — 80 joint filings, latest 2019-08-30
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
GENOMIC HEALTH INC (GHDX) Delisted Director 1,277,947 — — -$462.73M 9 2019-04-10

Recent Filings

9 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2019-04-10 GENOMIC HEALTH INC (GHDX) Delisted Sell (S) −131,460 -$9.09M EDGAR
2019-03-14 GENOMIC HEALTH INC (GHDX) Delisted Sell (S) −1,544,330 -$117.03M EDGAR
2019-01-25 GENOMIC HEALTH INC (GHDX) Delisted Sell (S) −2,088,310 -$150.06M EDGAR
2018-11-13 GENOMIC HEALTH INC (GHDX) Delisted Sell (S) −1,837,590 -$151.31M EDGAR
2018-11-13 GENOMIC HEALTH INC (GHDX) Delisted Sell (S) −727,450 -$62.25M EDGAR
2018-01-03 GENOMIC HEALTH INC (GHDX) Delisted Grant (A) +35,040 $1.20M EDGAR
2016-08-15 GENOMIC HEALTH INC (GHDX) Delisted Buy (P) +1,000,000 $27.02M EDGAR
2016-01-05 GENOMIC HEALTH INC (GHDX) Delisted Grant (A) +34,080 $1.20M EDGAR
2014-07-03 GENOMIC HEALTH INC (GHDX) Delisted Grant (A) +42,960 $1.20M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.